A - Agilent Technologies, Inc.
| Previous Close | 70.82 |
| Open | 71.29 |
| Bid | 52.60 x 800 |
| Ask | 0.00 x 1400 |
| Day's Range | 70.85 - 72.31 |
| 52 Week Range | 60.42 - 75.11 |
| Volume | 1,551,657 |
| Avg. Volume | 2,701,056 |
| Market Cap | 22.912B |
| Beta (3Y Monthly) | 1.27 |
| PE Ratio (TTM) | 74.15 |
| EPS (TTM) | 0.97 |
| Earnings Date | Feb 20, 2019 |
| Forward Dividend & Yield | 0.66 (0.93%) |
| Ex-Dividend Date | 2018-12-28 |
| 1y Target Est | 78.54 |
- Barrons.com•2 days ago
Five Ways to Profit from the Boom in Life Science
Stocks of companies that make diagnostic health products have had a strong run, and with increased demand and plenty of money for R&D, more gains could be on the way.
- Zacks•3 days ago
TE Connectivity (TEL) Q1 Earnings: What's in the Cards?
TE Connectivity's (TEL) fiscal first-quarter 2019 results are expected to benefit from robust solutions portfolio and normalizing seasonal trend in the end-markets.
- Zacks•3 days ago
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
Waters' (WAT) strong segmental and end-market performance is likely to drive fourth-quarter 2018 results.
- Business Wire•4 days ago
Mala Anand to Join Agilent’s Board of Directors
Agilent Technologies, Inc. (NYSE:A) today announced that Mala Anand, president, Intelligent Enterprise Solutions and Industries has been elected to its board of directors, effective March 20, 2019. Prior to that, Ms. Anand served as the Senior Vice President, Data & Analytics and Automation Software Platform group at Cisco Systems, Inc. from 2007 to 2016. “Mala is an outstanding addition to our board,” said Koh Boon Hwee, Agilent chairman.
- Business Wire•5 days ago
Agilent Recognized by Forbes as One of America’s Best Employers for Diversity
Agilent Technologies Inc. (NYSE:A) today announced that it has been recognized by Forbes as one of America’s Best Employers for Diversity 2019. Agilent is ranked number 53 of the 500 companies on the list. “We’re proud to be named as one of America’s Best Employers for Diversity,” said Dominique Grau, senior vice president, Agilent Human Resources.
- Markit•6 days ago
See what the IHS Markit Score report has to say about Agilent Technologies Inc.
# Agilent Technologies Inc ### NYSE:A View full report here! ## Summary * Perception of the company's creditworthiness is positive * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is extremely low for A with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting A. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $12.46 billion over the last one-month into ETFs that hold A are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. ## Credit worthiness Credit default swap | Positive The current level displays a positive indicator. A credit default swap spreads are near the lowest level of the last three years and indicate the market's continued positive perception of the company's credit worthiness. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•7 days ago
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Markit•12 days ago
See what the IHS Markit Score report has to say about Agilent Technologies Inc.
# Agilent Technologies Inc ### NYSE:A View full report here! ## Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is extremely low for A with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting A. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, growth of ETFs holding A is favorable, with net inflows of $20.99 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. ## Credit worthiness Credit default swap | Positive The current level displays a positive indicator. A credit default swap spreads are near the lowest level of the last three years and indicate the market's continued positive perception of the company's credit worthiness. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Simply Wall St.•16 days ago
Have Insiders Been Selling Agilent Technologies, Inc. (NYSE:A) Shares?
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders Read More...
- Barrons.com•23 days ago
Gold Can Keep Glittering in 2019
Continued stock market turmoil could finally make the precious metal a winner again. Plus, key events for the week of Monday, Dec. 31, through Friday, Jan. 4
- American City Business Journals•23 days ago
Ex-Swedish neurosurgeon sues Washington state employees who suspended his medical license
Dr. Johnny Delashaw's lawyers claim the state employees cut corners and bowed to media and political pressure in suspending his license.
- Kiplinger•last month
6 Genome Sequencing Stocks to Buy for Big Health-Care Profits
Genome sequencing - basically figuring out the order of DNA, the building blocks of life - was once essentially little more than a lab exercise. But now, it has reached commercial viability and then some. The field of genomics goes back to the 1950s, though it really started in earnest with the start of the Human Genome Project in 1990 - a 13-year, $2.7 billion enterprise that was completed in April 2013. Genome sequencing, in which scientists and their myriad machines detail the entire set of human DNA, has fantastic medical potential, allowing researchers to find genetic mutations - errors that can be harmless at times, but other times debilitating or even fatal. Moreover, genome sequencing is starting to reach realistic pricing - the costs have fallen down to about $1,000 at the low end, and companies are racing to cash in on the myriad opportunities. Here are six genome sequencing stocks to buy for this emerging medical technology. While genomics isn't the biggest investing buzzword today, this is a promising niche of the market that could take off as it gains more prominence. SEE ALSO: 19 Best Retirement Stocks to Buy in 2019
- GuruFocus.com•last month
Agilent Technologies Inc (A) Files 10-K for the Fiscal Year Ended on October 31, 2018
Agilent Technologies Inc is engaged in life sciences, diagnostics and applied chemical markets. The dividend yield of Agilent Technologies Inc stocks is 0.92%. Agilent Technologies Inc had annual average EBITDA growth of 4.90% over the past ten years.
- Business Wire•last month
Agilent Receives 2018 Innovation Award from The Analytical Scientist
Agilent Technologies Inc. (NYSE:A) today announced that the latest addition to its infrared spectroscopy portfolio has been recognized as one of 2018’s best analytical advances. The Analytical Scientist ranked the Agilent 8700 Laser Direct Infrared (LDIR) Chemical Imaging System among this year’s top innovations. Agilent introduced the 8700 LDIR chemical imaging system in October.
- Business Wire•last month
Agilent Technologies to Present at Goldman Sachs Healthcare CEO Conference and JP Morgan Healthcare Conference
Agilent Technologies Inc. today announced the following webcasts for the investment community:
American City Business Journals•last monthHealth Care Digest: Tracking Nashville's beat, cellular peepers and more
Why this San Francisco-based VC is investing in health care, nursing homes and keeping an eye on Nashville.
American City Business Journals•last monthFresh off Wichita visit, NASA seeks new industry partnerships for moon missions
NASA Administrator Jim Bridenstine said during a recent trip to Wichita that the kind of innovation happening locally would be key to NASA's future programs.
- TechCrunch•last month
Companies tracking mutations in cancer cells can provide a key to unlocking better therapies
Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create more targeted therapies. Earlier this month, research using technology developed by the startup Mission Bio helped identify cellular mutations in acute myeloid leukemia cancer cells that could be indicators of potential relapse or recurrence of the cancer after therapy. In the study, which was presented at the American Society for Hematology's recent conference, a team from the MD Anderson cancer research institute in Texas, including Dr. Koichi Takahashi, sequenced more than 500,000 cells across 70 patients using Mission Bio's "Tapestri" platform.
- Simply Wall St.•last month
All You Need To Know About Agilent Technologies, Inc.’s (NYSE:A) Financial Health
Agilent Technologies, Inc. (NYSE:A), a large-cap worth US$23b, comes to mind for investors seeking a strong and reliable stock investment. Most investors favour these big stocks due to their strong Read More...
Markit•last monthSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- American City Business Journals•last month
New Spirit AeroSystems CFO contract includes large signing bonus
The new CFO at Spirit AeroSystems Inc. in Wichita will make more in his first year with the company through a signing bonus than he will in initial base salary. According to a filing by Spirit (NYSE: SPR) with the U.S. Securities and Exchange, Jose Ignacio Garcia will begin work at the company with an annual salary of $615,000. But Garcia, named the new CFO on Monday, will also receive a $750,000 cash signing bonus. The filing states that $250,000 of that will be paid no later 30 days from his effective employment date. Spirit said in announcing Garcia as the successor to retiring CFO Sanjay Kapoor that his start date with the company would be Jan. 9, 2019. The remaining $500,000 from the signing bonus will be paid no later than his first work anniversary. The filing also indicates that Garcia’s initial salary may be increased “from time to time,” based on performance and that he will also be eligible for annual awards under the company’s short- and long-term incentive plans. He will also receive sign-on equity awards (company stock) equal to $1.5 million. Garcia comes to Spirit after more than two decades with General Electric Co. (NYSE: GE), the same company where Spirit CEO Tom Gentile also compiled two decades of experience before joining Wichita’s largest employer in 2016. Garcia was most recently the vice president and CFO of Paris-based GE Renewable Energy. He holds a bachelor’s degree in business administration and management and a master’s degree in business administration from ESADE Business School in Spain. The company also says in the filing that Kapoor will transition to the role of senior financial advisor once Garcia joins Spirit, and will stay on in that role through his retirement date of March 31, 2019.
- Motley Fool•last month
Here's Why Twist Bioscience Stock Soared 89% in November
The DNA synthesis leader had a great month following its IPO.
Markit•last monthSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
GuruFocus.com•last monthTop 5 Buys of the Signature Select Canadian Fund
The Signature Select Canadian Fund (Trades, Portfolio), part of CI Investments Inc., released its semi-annual portfolio this week, listing 20 new positions. Warning! GuruFocus has detected 2 Warning Signs with NCLH. Managed by Eric Bushell, the Toronto-based fund invests in a diverse assortment of Canadian companies to achieve long-term capital appreciation and dividend income.
- InvestorPlace•2 months ago
10 Boring Stocks to Buy for Red-Hot Returns
